Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The aim of this exploratory investigation is to evaluate if the Forced Expiratory Volume in
the 1st second (FEV1) measurements, fractional exhaled nitric oxide (FENO) and Provocative
Concentration 20 (PC20) after Adenosine Monophosphate (AMP) bronchial challenge evaluated
after administration of a fixed combination of a Long-acting Beta-2-agonist (LABA) and an
Inhaled Corticosteroid (ICS) at increasing doses may be suitable to demonstrate a dose
response.